Patent · US Active

Immunoassays for lamotrigine

US8592564B2 · kind B2 · utility

0Cited by
18References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 25, 2010
Grant dateNov 26, 2013
Priority date
Expiry dateApr 11, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/13
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Generally, the present invention relates to lamotrigine analogs that have substituents at the triazine 3-position and on the benzene 4-position and 5-position. The lamotrigine analogs can include immunogenic moieties that can be used to prepare anti-lamotrigine antibodies, or antigenic moieties that can be used in immunodiagnostic assays for lamotrigine. Also, the lamotrigine analog can include tracer moieties for detecting the presence or amount of the analog during an immunodiagnostic assay. Additionally, the lamotrigine analogs can be used in immunodiagnostic assays to compete with lamotrigine for binding with anti-lamotrigine antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.